Literature DB >> 12574941

The future of association studies of common cancers.

Richard S Houlston, Julian Peto.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12574941     DOI： 10.1007/s00439-002-0902-4

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


× No keyword cloud information.
  10 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

Review 2.  Genetics and the common cancers.

Authors:  J Peto; R S Houlston
Journal:  Eur J Cancer       Date:  2001-10       Impact factor: 9.162

Review 3.  Cancer genetics.

Authors:  B A Ponder
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Tests and estimates of allelic association in complex inheritance.

Authors:  N E Morton; A Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

5.  The future of genetic studies of complex human diseases.

Authors:  N Risch; K Merikangas
Journal:  Science       Date:  1996-09-13       Impact factor: 47.728

6.  Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE.

Authors:  K Lange; D Weeks; M Boehnke
Journal:  Genet Epidemiol       Date:  1988       Impact factor: 2.135

7.  High constant incidence in twins and other relatives of women with breast cancer.

Authors:  J Peto; T M Mack
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

8.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

9.  Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.

Authors:  Hanne Meijers-Heijboer; Ans van den Ouweland; Jan Klijn; Marijke Wasielewski; Anja de Snoo; Rogier Oldenburg; Antoinette Hollestelle; Mark Houben; Ellen Crepin; Monique van Veghel-Plandsoen; Fons Elstrodt; Cornelia van Duijn; Carina Bartels; Carel Meijers; Mieke Schutte; Lesley McGuffog; Deborah Thompson; Douglas Easton; Nayanta Sodha; Sheila Seal; Rita Barfoot; Jon Mangion; Jenny Chang-Claude; Diana Eccles; Rosalind Eeles; D Gareth Evans; Richard Houlston; Victoria Murday; Steven Narod; Tamara Peretz; Julian Peto; Catherine Phelan; Hong Xiang Zhang; Csilla Szabo; Peter Devilee; David Goldgar; P Andrew Futreal; Katherine L Nathanson; Barbara Weber; Nazneen Rahman; Michael R Stratton
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

10.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.

Authors: 
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640
  10 in total
  14 in total

1.  Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis.

Authors:  Aung Ko Win; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

2.  Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.

Authors:  Qiang Fu; Guoqiang Zhang; Hongwei Chen; Youwei Zheng; Jing Cheng
Journal:  Tumour Biol       Date:  2013-08-03

3.  Power analysis for case-control association studies of samples with known family histories.

Authors:  Bo Peng; Biao Li; Younghun Han; Christopher I Amos
Journal:  Hum Genet       Date:  2010-04-11       Impact factor: 4.132

4.  Mutation analysis of the AATF gene in breast cancer families.

Authors:  Maria Haanpää; Mervi Reiman; Jenni Nikkilä; Hannele Erkko; Katri Pylkäs; Robert Winqvist
Journal:  BMC Cancer       Date:  2009-12-21       Impact factor: 4.430

5.  Common genetic variants in candidate genes and risk of familial lymphoid malignancies.

Authors:  Xueying Sharon Liang; Neil Caporaso; Mary Lou McMaster; David Ng; Ola Landgren; Meredith Yeager; Stephen Chanock; Lynn R Goldin
Journal:  Br J Haematol       Date:  2009-07-01       Impact factor: 6.998

6.  Possible imprinting and microchimerism in chronic lymphocytic leukemia and related lymphoproliferative disorders.

Authors:  Viggo Jønsson; Geir E Tjønnfjord; Tom B Johannesen; Sven Ove Samuelsen; Bernt Ly
Journal:  Transl Oncogenomics       Date:  2008-02-10

7.  TP53-binding protein variants and breast cancer risk: a case-control study.

Authors:  Bernd Frank; Kari Hemminki; Justo Lorenzo Bermejo; Rüdiger Klaes; Peter Bugert; Barbara Wappenschmidt; Rita K Schmutzler; Barbara Burwinkel
Journal:  Breast Cancer Res       Date:  2005-05-06       Impact factor: 6.466

8.  BACH1 Ser919Pro variant and breast cancer risk.

Authors:  Pia Vahteristo; Kristiina Yliannala; Anitta Tamminen; Hannaleena Eerola; Carl Blomqvist; Heli Nevanlinna
Journal:  BMC Cancer       Date:  2006-01-24       Impact factor: 4.430

9.  Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study.

Authors:  Barbara Burwinkel; Kalai S Shanmugam; Kari Hemminki; Alfons Meindl; Rita K Schmutzler; Christian Sutter; Barbara Wappenschmidt; Marion Kiechle; Claus R Bartram; Bernd Frank
Journal:  BMC Cancer       Date:  2006-11-17       Impact factor: 4.430

10.  TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk.

Authors:  J Skoglund Lundin; J Vandrovcova; B Song; X Zhou; M Zelada-Hedman; B Werelius; R S Houlston; A Lindblom
Journal:  Br J Cancer       Date:  2009-04-28       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.